In 2018, Novo Nordisk faced an opportunity and an equally large obstacle. The Danish pharmaceutical company, which is focused on treating and curing diabetes, rare bleeding and growth hormone disorders, and obesity, had a rapidly expanding pipeline, which meant that demand for content to support commercialization was also going to expand. The prospect of a threefold increase in the cost of content production and increased use of an already cumbersome review and approval process, compelled Novo Nordisk to look for a way to handle the growth. It chose Veeva Vault PromoMats to be its digital asset management system and set out to transform its approach to content creation.

Join for free to read